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I. Relevant Issues
A. Preventable Risks:
1. Short term
a. Hypercalcemia
b. Renal and other stones
2. Long term - Skeletal atrophy
B. Medical Questions:
1. Does hypercalcemia occur?
2. What are the changes in urine concentration?
3. What is the rate of an individual's bone loss?
4. How long does it take to recover bone after
return to Earth? Is there a postcareer hazard
regarding bone loss?
5. Is an exercise or pharmacological
countermeasure needed for this length flight? Is the
exercise or pharmacological countermeasure
prescribed working?
C. Medical Operations Evaluation Requirements:
1. Ionized calcium determinations- in flight
2. Metabolic balance for calcium - collections in
flight, analysis on Earth
3. Bone densitometry- in flight
4. Mineral and hormonal determinations -
collections in flight, analysis on Earth
II. Background: Bone and Mineral Metabolism
Biomedical data from multiple U.S. and
U.S.S.R. space missions are making it clear that there
are continuous and possibly progressive changes in
the musculoskeletal system. This effect appears in the
way the body conserves calcium and other minerals
which are normally stored in the skeleton. Loss of
total-body calcium and skeletal changes have been
observed in both animals and people who have flown
from 1 week to more than 237 days in space. These
alterations in bone and mineral metabolism may be
among the most profound biomedical changes
associated with long-duration space flight.
Information on skeletal and mineral changes has been
obtained from a variety of studies conducted in both
simulated and actual space flight.
Bone Density Studies
During Apollo and Skylab missions, a precise
method of photon absorptiometry was used to assess
preflight and postflight bone mineral mass. The
results of measurements of the central os calcis, which
is almost all trabecular bone, for the Skylab Program
(ref. 1) revealed that the largest losses occurred on the
crew of Skylab 4 after 84 days of weightlessness. Bone
mineral losses were not observed from the distal
compact radius, however. Since these measurements
were taken from different types of bone, they do not
answer the important question of whether mineral
loss occurs only in weight-bearing bones during space
flight. Some suggestion is found from the U.S.S.R.
space-flight measurements in which mineral loss was
determined from the tubercle and plantar areas of the
os calcis, predominately compact bone. Bone loss
seemed to increase in rough proportion to the
increase in mission length and ranged from -0.9 to
-19.8 percent over periods from 75 to 184 days (ref. 2).
Thus, both compact and trabecular bone is lost from
the heel. Calcaneal mineral recovery is gradual and
appears to take about the same length of time as the
loss (ref. 3). This measured recovery was incomplete in
at least one Skylab 4 astronaut, who, after 90 days
back on Earth, had replaced only half his loss.
Although U.S.S.R. investigators suggest that full
calcaneal recovery occurs, spine mineral loss was seen
in cosmonauts (using an x-ray computerized
tomography technique) during the 6 months
following flight, but, using the same technique, no
loss of spine mineral was seen during flight (ref. 4).
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Calcium Balance Studies
Studies of metabolic balance were conducted
on the Skylab missions, during which dietary intake
and urinary and fecal excretion were monitored.
Daily reports of food ingested by individual
crewmembers were communicated to dietary
personnel, who calculated daily intake of calories,
minerals, and other nutrients. Twenty-four-hour
urine collections were mixed with a known quantity
of a marker, and an aliquot was obtained and saved
for analysis back on Earth. All stools were collected
and returned for analysis. (However, enemas were
used just prior to launch and the excreta discarded.)
Sweat minerals were not measured, nor was any
correction made for sweat losses. Vomitus may or may
not have been saved for laboratory analysis. Despite
the problems in balance technique, Skylab balance
studies were more accurate than were the balance
determination studies on the few crewmembers
participating in the Gemini and Apollo missions.
Results of these studies showed that space flight is
accompanied by an increased excretion of calcium and
phosphorus.
The changes in urine and fecal calcium content
were measured in flight during Skylab 4 (ref. 5). The
urine calcium content increased rapidly but reached a
plateau after 30 days in flight. There was a small fecal
calcium increase seen over the duration of the flight.
Within 10 days in flight, the preflight positive calcium
balances became less positive until the body as a
whole began to lose calcium. The rate of loss was slow
at first, but increased to almost 300 milligrams per day
by the 84th day of flight. For the three Skylab 4
crewmen, the average loss was 25 grams of calcium
from the overall body pool (about 1250 grams). Based
on the trends in calcium loss during the first 30 days in
flight, Rambaut and Johnston (ref. 1) calculated that
1 year in flight might result in the loss of 300 grams, or
25 percent, of the initial body pool. Similar
conclusions can be drawn from U.S.S.R. research
(ref. 6), in which an increased calcium excretion is
attributed to weightlessness.
Results of the Skylab calcium balance studies
suggest that the losses in bone mineral from the os
calcis contribute relatively little to the overall calcium
loss. A 4-percent loss observed in the os calcis after
the 84-day mission would represent a loss of only
about 100 milligrams of calcium, whereas overall
calcium loss for this mission was 250 times greater. In
one U.S.S.R. mission in which substantial exercise was
performed by the cosmonauts, significant loss of os
calcis mass was also seen, although the investigators
think that an extensive exercise program on later
missions did decrease skeletal loss (ref. 7). Thus, it is
clear that other weight-bearing skeletal sites account
for the major portion of the depleted mineral. Bone
loss from other skeletal sites has not been reported.
Recovery of the lost calcium begins soon after
return to one g. Urine calcium content dropped
below preflight baseline by postflight day 10, but
fecal calcium content had not dropped to preflight
levels by 20 days after flight. The markedly negative
calcium balance also had not returned to zero by day
20. Evidence from the studies on recovery of the os
calcis mineral content after space flight, and evidence
from bed-rest studies, suggests that after a period of
some weeks or months, the astronaut would return to
his/her normal os calcis bone mineral content.
Nevertheless, it is possible that the calcium balance
might return to zero long before the loss from space
flight had been made up, and irreversible damage to
the skeleton might result.
Biochemical Analyses
Analyses of in-flight urine, fecal, and plasma
samples from Skylab missions revealed changes in a
number of biochemical parameters (ref. 8). Urinary
output of hydroxyproline gradually increased,
indicating the deterioration of the collagenous matrix
substance of weight-bearing bones. Output of
nitrogen reflecting muscle atrophy also increased.
The proportion of stearic acid in the total fecal fat
increased throughout the flight as more and more
calcium was available to form nonabsorbable salts.
Urinary levels of catecholamines decreased but
urinary cortisol was increased during space flight.
Analyses of plasma revealed in-flight increases in
calcium and phosphate; parathyroid hormone (PTH)
levels were never increased and were decreased from
preflight or early flight levels later in the flight (refs. 1,
9, and 10).
Ground-Based Simulation Models
Bed rest provides a good model for the
changes of weightlessness on bone and mineral since
the force of gravity is reduced on the longitudinal
skeleton from one g to one-sixth g. Although the
results from space-flight balance studies are not
completely identical to the bed-rest model, a number
of factors must be considered. These include the
ability to perform a greater number of studies on
Earth and thereby to minimize individual variations
and the capability for more critical monitoring of
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subjects, minimizing mineral losses from sweat and
vomitus during ambulatory control, bed rest, and
recovery (compared to the lack of these controls in the
astronauts before flight, during flight with early space
motion discomfort or later exercise periods, and after
flight during physiologic recovery). The lack of
measurement of these mineral losses could become a
standard error of the balance studies during space
travel. Balances would initially appear positive and
during space flight would remain positive, although
less so. If the mineral losses from sweat and vomitus
were not measured only during part of the space
flight as would be seen with variation of cabin
temperature changes, space motion discomfort, or
exercise effort, mineral balance would appear to be
inconsistent. Thus, space balance studies have
pointed the way but must be interpreted with
caution. Bed-rest studies have given reliable and
reproducible results which have allowed us the
opportunity to determine that bone loss continues
unabated for at least 36 weeks with no evidence that
the expected new steady state is produced. Total-
body calcium stores decrease by 6 grams each month
after the first month of bed rest, and by the end of 9
months, at least 50 grams of calcium have been lost.
Additionally, bed rest allows us to determine results
that bear on the mechanisms underlying bone loss
during hypokinesic states.
Bed-rest studies have suggested a means to
predict the amount of mineral that will be lost from
the os calcis during bed rest or in space (refs. 11 to 15).
The wide variability in the amount of lost mineral in
bed-rested subjects can partly be accounted for by
two other variables: (1) the initial os calcis mineral
content and (2) the urinary hydroxyproline excretion
rate (corrected for creatinine excretion). The
regression of the prediction term (initial mineral
divided by urinary hydroxyproline excretion rate) on
the amount of mineral loss in subjects bed-rested for
59 days has been determined (ref. 3). The fact that
data from two of the Skylab 3 astronauts fit well
suggests that these variables also can be used to
predict the effects of space flight on os calcis mineral
content.
Studies of animals with immobilized limbs
have suggested that disuse produces changes in both
bone formation and bone resorption, depending
upon the length of immobilization. For example,
Landry and Fleisch (ref. 16) used osseous tetracycline
incorporation corrected by changes in bone weight as
a direct index of bone formation, and as an indirect
index of bone resorption. They found a short initial
phase during which formation decreased, and a
second phase in which formation increased but bone
weight decreased, indicating an even greater increase
in resorption. After 49 days of immobilization,
formation again decreased below normal levels.
Young et al. (ref. 17), through long-term
immobilization of monkeys (Macaca nemestrina),
demonstrated loss of not only trabecular bone but
cortical bone in the weight-bearing areas. Moreover,
full recovery of the cortical bone deficiencies may not
have been complete even after 40 months of ad lib
activity followi ng restrai nt.
Didenko and Volnzhin (ref 18) e_posed
rabbits to 30 days of confinement in order to study
changes in bone mineral composition. Levels of
calcium in bone did not change, although calcium
excretion increased. This effect was attributed to an
inhibition of bone reorganization, in which bone mass
was reduced without a corresponding alteration of
crystalline structure.
The most pronounced changes are seen to
occur in weight-bearing bones. Mechanical
stimulation apparently has a critical effect on bone
structure and metabolism, as numerous studies
involving bone strain measurement have shown (ref.
19). There also appears to be an age-dependent
variation in the relative rates of bone formation and
resorption (ref. 20). Older animals show the highest
net rate of bone loss during immobilization.
These and other results indicate that
immobilization produces a number of time-
dependent changes in bone accretion and resorption,
and suggest that proportionately larger increases in
resorption may be a key factor in the loss of bone
mineral mass. Skeletal losses in space are likely due to
relatively larger increases in bone resorption
compared to bone formation (except in immature
growing animals). Autopsies of the three U.S.S.R.
cosmonauts who died after a 21-day flight revealed "a
good number of unusually wide osteocytic lacunae,"
which may have been due to increased bone
resorption.
In-Flight Animal Experiments
Studies of animals flown aboard the Cosmos
satellites (ref. 21) and in Space lab have also revealed
changes in bone mineral content. Monkeys
experiencing 8.8 days of weightlessness showed larger
losses in bone mineral than did ground controls (ref.
22). Spacelab 3 rat studies as well as previous studies
flown on the Cosmos biosatellites showed marked
skeletal changes. For example, skeletal changes in rats
exposed to as little as 7 days of space flight during
Spacelab 3 included decreased bone growth,
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rdecreased mineralization, decreased bending
strength, and decreased weight of the lumbar spines
(L3) (refs. 23 and 24). Flight rats after 18.5 days in the
Cosmos experiment showed a 30-percent decrease in
mechanical bending strength (ref. 25) compared to a
28-percent reduction in rats aboard Spacelab 3 after
just 7 days (ref. 26). In addition to these changes,
other functional rearrangements such as depression in
bone cell size and number at the bone surface have
been documented (ref. 27). However, no change was
seen in either qualitative or quantitative function of
rat kidney calcitriol receptors and thus no causal or
effectual role by the system in regulating renal
calcium loss was suggested (ref. 28). These and other
studies have suggested that the loss of bone mineral
in growing rats might be primarily due to inhibited
bone formation rather than increased bone
resorption (refs. 29 and 30). Rats on the 22-day
Cosmos 605 flight showed decreased metaphyseal
bone in the vicinity of the epiphyseal cartilaginous
plate, suggesting an inhibition of bone growth during
flight. It is not yet possible to integrate these findings
with the findings from hypokinesia studies on humans
and animals in oneg because of the complicating
factors of time-dependent changes, species
differences, and potential differences in the
mechanisms by which bone is lost in space and in bed
rest or immobilization.
Countermeasures
The major countermeasures being explored to
reduce the effects of space flight on the skeleton are
the use of various weight-loading exercises or
artificial-gravity regimens that counteract the loss of
gravitational and muscular stress, and nutritional and
pharmacological manipulations. The crews of Skylab
3 and 4 exercised heavily in flight Three of these six
people showed substantial mineral losses, which casts
doubt on the effectiveness of the particular exercises
used as a countermeasure. Findings of U.S.S.R.
investigators regarding the effect of in-flight exercise
during long-duration space flights have been
inconsistent (ref. 7). Nutritional supplements of
calcium and phosphorus for short periods of time, and
drugs such as fluoride or clodronate, a
disphosphonate, show some promise as
countermeasures for the effects of bed rest on the
skeleton and may be effective for space flight.
Because of technical and hardware constraints,
artificial gravity has so far been employed only in
animal studies, but results have been quite promising.
Centrifugation has been shown to prevent changes in
calcium and phosphorus content of rat long bones
(ref. 25) and to prevent osteoporosis (ref. 31).
Summary and Conclusions
Based on the information obtained from space
missions, particularly Skylab and the longer Salyut
missions, it is clear that bone and mineral metabolism
is substantially altered during space flight. Calcium
balance becomes increasingly more negative
throughout the flight, and the bone mineral content
of the os calcis declines. The major health hazards
associated with skeletal changes include the signs and
symptoms of hypercalcemia with rapid bone turnover,
the risk of kidney stones because of hypercalciuria, the
lengthy recovery of lost bone mass after flight, the
possibility of irreversible bone loss (particularly the
trabecular bone), the possible effects of metastated
calcification in the soft tissues, and the possible
increase in fracture potential.
For these reasons, major efforts need to be
directed toward elucidating the fundamental
mechanisms by which bone is lost in space and
developing more effective countermeasures to
prevent both short-term and long-term complications.
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